Sanford C. Bernstein Downgrades Demant A/S (OTCMKTS:WILYY) to Hold

Demant A/S (OTCMKTS:WILYY) was downgraded by Sanford C. Bernstein from a “strong-buy” rating to a “hold” rating in a research report issued on Friday,Zacks.com reports.

A number of other research analysts have also weighed in on WILYY. Zacks Research raised Demant A/S to a “hold” rating in a research note on Friday, June 26th. Morgan Stanley upgraded Demant A/S from an “equal weight” rating to an “overweight” rating in a research note on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Demant A/S currently has a consensus rating of “Moderate Buy”.

Demant A/S Stock Performance

Demant A/S stock opened at $20.66 on Friday. Demant A/S has a fifty-two week low of $13.45 and a fifty-two week high of $20.98. The stock’s fifty day moving average is $19.43 and its two-hundred day moving average is $16.86. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00.

Demant A/S Company Profile

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.